[Histonet] RE: [IHCRG] ER clone 1D5 or SP1 ?

2010-04-28 Thread Patsy Ruegg
Michael, Thanks for clarifying that. Patsy Patsy Ruegg, HT(ASCP)QIHC IHCtech, LLC Fitzsimmons BioScience Park 12635 Montview Blvd. Suite 215 Aurora, CO 80010 P-720-859-4060 F-720-859-4110 wk email pru...@ihctech.net web site www.ihctech.net This email is confidential and intended

[Histonet] RE: [IHCRG] ER clone 1D5 or SP1 ?

2010-04-26 Thread Van Eyck, Deb
This is a great discussion lets also talk about PR clones since the ASCO/CAP guidelines just came out --Hadi or Rich I know they only list two PR clones one is Dako 1294-what is the other 312? Deb From: ih...@googlegroups.com

[Histonet] RE: [IHCRG] ER clone 1D5 or SP1 ?

2010-04-26 Thread Patsy Ruegg
Did I understand correctly from Dr. Hammond in Florida that the ER ASCO/CAP guidelines extended the fixation time to 72 hours? Are they changing the Her2 guidelines to match the ER? If so, has that happened yet? I have people very anxious to stop having techs work on the weekends to comply with

[Histonet] RE: [IHCRG] ER clone 1D5 or SP1 ?

2010-04-26 Thread Van Eyck, Deb
Thanks Michael I saw table 10 -but on page 16 they specifically only list clone 1294 and 312 (which is whose?) -they really don't clearly say all clones for PR listed in table 10. They also only refer to these two again on the shortened ASCO color plate handout Additional information in re:

[Histonet] Re: [IHCRG] ER clone 1D5 or SP1 ?

2010-04-25 Thread Richard Cartun
I have looked at several clones over the years and I prefer clone 6F11. Richard Richard W. Cartun, Ph.D. Director, Histology Immunopathology Director, Biospecimen Collection Programs Assistant Director, Anatomic Pathology Hartford Hospital 80 Seymour Street Hartford, CT 06102 (860) 545-1596

[Histonet] Re: [IHCRG] ER clone 1D5 or SP1 ?

2010-04-25 Thread ancillarypath
When we started our lab 3 years ago, we began with SP1 from day 1, so I don't have any experience with either 1D5 or 6F11 except in my previous labs. 1D5 is an excellent clone, and seems to be more specific than SP1 in the work-up of metastatic carcinoma of unknown primary site, based on